Article
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Carcinogenesis - 1 Apr 2012
Hu Zhibin, Dong Jing, Wang Li-E, Ma Hongxia, Liu Jibin, Zhao Yang, Tang Jinhai, Chen Xi, Dai Juncheng, Wei Qingyi, Zhang Chenyu, Shen Hongbing
Abstract excerpt
It has been demonstrated that there are abundant stable microRNAs (miRNAs) in plasma/serum, which can be detected and are potentially disease specific. However, the lack of suitable endogenous controls for serum miRNA detection is the restriction for the widely usage of this kind of biomarkers and for the between-laboratory comparison of the findings. We first systematically screened for endogenous control miRNAs...
Topics
Join the communities discussing this publication.